Walleye Capital’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Walleye Capital's DNA Position: Q3 2026 in Review
Walleye Capital increased its Ginkgo Bioworks (DNA) stake by 729% in Q3 2026, buying an estimated $1.13M and bringing the position to 158,116 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2805.
Walleye Capital first reported a position in DNA in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.61M in Q4 2024. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Walleye Capital held 158,116 shares of Ginkgo Bioworks worth $2.03M as of Q3 2026.
- Walleye Capital bought 139,050 Ginkgo Bioworks shares in Q3 2026, an estimated $1.13M.
- Ginkgo Bioworks made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2805 holding.
- Walleye Capital first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 5 quarters since.
- Walleye Capital's Ginkgo Bioworks position peaked at $2.61M in Q4 2024.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.